Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Two Step Haplo With Radiation Conditioning

NCT05031897

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma, +61 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadephia, Pennsylvania, United States

View Trial Details

Recruiting

Living Well With Lymphoma

NCT06047626

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Recruiting

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

NCT05363111

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations: Massive Bio SYNERGY-AI site Birmingham, Alabama, United States

Massive Bio SYNERGY-AI site Mobile, Alabama, United States

Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States

Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Recruiting

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

NCT06796998

Conditions: Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

NCT02848274

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: City of Hope Duarte, California, United States

Stanford University, School of Medicine Palo Alto, California, United States

University of Iowa Iowa City, Iowa, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View all 13 locations

View Trial Details

Recruiting

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

NCT06828991

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Wilmot Cancer Institute Rochester, New York, United States

View Trial Details

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NCT05890352

Conditions: Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations: Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

Tower Cancer Research Foundation Beverly Hills, California, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View all 104 locations

View Trial Details

Recruiting

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

NCT02508038

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +40 more
Locations: University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Recruiting

WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

NCT07058064

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions